These findings strongly imply that high BTBD19 expression might be linked to a poor prognosis in CRC, suggesting that BTBD19 could potentially serve as a valuable biomarker for predicting the outcome of CRC patients. The gene discussed is BTBD19; the disease is colorectal carcinoma.